Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 11Myeloid 3Dermatologic 3Thoracic 2Head & Neck 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 5760Lung Neoplasms 3725Small Cell Lung Carcinoma 1021Breast Neoplasms 668Neoplasms 615Colorectal Neoplasms 562Melanoma 479Ovarian Neoplasms 435Neoplasm Metastasis 432Pancreatic Neoplasms 387Stomach Neoplasms 332Carcinoma, Renal Cell 312Adenocarcinoma of Lung 309Squamous Cell Carcinoma of Head and Neck 306Head and Neck Neoplasms 295Prostatic Neoplasms 285Mesothelioma, Malignant 281Esophageal Neoplasms 266Mesothelioma 244Colonic Neoplasms 226Brain Neoplasms 217Urinary Bladder Neoplasms 212Triple Negative Breast Neoplasms 212Uterine Cervical Neoplasms 209Endometrial Neoplasms 175Sarcoma 172Carcinoma, Hepatocellular 159NSCLC 136Carcinoma 128Kidney Neoplasms 127

Interventions

desloratadine 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Pruritus × Thoracic × Clear all
NCT03992664 2025-02-13

Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.

Cyprus University of Technology

Phase NA Completed
40 enrolled
BreastGastrointestinalHead & NeckThoracic

Breast Neoplasms, Colonic Neoplasms, Exanthema, Head and Neck Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Photosensitivity Disorders, Pruritus

NCT02646020 2021-05-18

EGFR-TKIs

Sun Yat-sen University

Phase 2 Completed
138 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pruritus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡